/Catalog/CJC-1295 (with DAC)
Growth Hormone

CJC-1295 (with DAC)

Also known as CJC-1295 DAC

Long-acting GHRH analog with a Drug Affinity Complex for albumin binding.

Overview

Adds a maleimidopropionic acid (DAC) moiety to modified GRF(1-29), enabling covalent binding to serum albumin and extending half-life to roughly 6–8 days.

Mechanism

GHRH receptor agonism with albumin-mediated extended exposure.

Research areas

  • Sustained GH release
  • IGF-1 elevation

Related peptides

CJC-1295 (no DAC)

Modified GHRH(1-29) analog with short plasma half-life.

View

Ipamorelin

Selective ghrelin receptor agonist (GHRP) with minimal cortisol / prolactin release.

View

Tesamorelin

GHRH analog FDA-approved for HIV-associated lipodystrophy.

View